Vaxcyte, Inc. (PCVX) Misses Q4 EPS by $4.13
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($5.63), $4.13 worse than the analyst estimate of ($1.50).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.
Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($5.63), $4.13 worse than the analyst estimate of ($1.50).
For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.